TVTX
USDTravere Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$32.600
Максимум
$34.605
Минимум
$32.310
Объем
0.26M
Фундаментальные показатели компании
Рыночная капитализация
3.1B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
2.25M
Биржа
NGM
Валюта
USD
52-недельный диапазон
Связанные новости
Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a
Связанные акции
APP
Applovin Corporation
NUVL
Nuvalent Inc.
TIVC
Tivic Health Systems Inc.
QS
QuantumScape Corporation
BTA
BlackRock Long-Term Municipal Advantage Trust Common Shares of Beneficial Interest
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.